Skip to content

Hyaluronic Acid and Uterine Synechiae

Non-stick Gel Applicated After Scraping Surgery for Natural Miscarriage and Uterine Synechiae Prevention

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02248376
Acronym
HYFACO
Enrollment
364
Registered
2014-09-25
Start date
2014-11-14
Completion date
2018-09-14
Last updated
2021-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Synechiae After Scraping for Natural Miscarriage

Keywords

Uterine synechiae Scraping surgery Natural miscarriage

Brief summary

The primary purpose of the study is to compare efficiency of a non-stick gel application after scraping surgery for natural miscarriage with no non-stick gel application after scraping surgery. Post-scraping uterine synechiae rate will be established at the diagnostical hysteroscopy 6-8 weeks after surgery.

Detailed description

Women patients coming for natural miscarriage will be compared according to whether a non-stick gel will be applicated or not after scraping surgery. 6-8 weeks after this surgery uterine synechiae rate will be established at a diagnostical hysteroscopy. Proofreading of this exam will be made by 2 experts at the end of the study without knowing the randomization arm. Long-term follow-up of the patients will be performed to evaluate the effect of the non-stick gel application on post-surgical fertility at 6, 12, and 24 months after scraping surgery using questionnaire asked by post, mail or phone.

Interventions

DRUGGel

Patients aged of more than 18 years-old coming for a natural miscarriage who will have the stick gel application at the end of the scraping surgery.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 46 Years
Healthy volunteers
No

Inclusion criteria

* Women patients aged between 18 and 46 years old * Term ≥ 7 weeks amenorrhea and ≤ 14 weeks amenorrhea * Blighted ovum or not completed miscarriage or haemorrhagic miscarriage or retention miscarriage * Consent signature * Social security coverage * Women who wants to be pregnant

Exclusion criteria

* Infected miscarriage * Uncertain diagnosis between miscarriage and extra-uterine pregnancy * Hydatiform mole * Uterine synechiae history * Surgical zone infection * Hyalobarrier® gel Endo hypersensitivity * Clotting disorder * Unstable diabetes * Maternal malignant diseases * Psychiatric disorder * Incapacity in understanding the consent form and the questionnaires * Law protected adult person

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of post-surgical uterine synechiae rate during a diagnostical hysteroscopy.6-8 weeks after scraping surgeryDiagnostical hysteroscopy performed 6-8 weeks after scraping surgery.

Secondary

MeasureTime frameDescription
Evaluation of the effect of the non-stick gel application on the post-surgical fertility 6, 12, and 24 months after scraping surgery.6, 12 and 24 months after scraping surgeryEvaluation using questionnaires asked by post, mail or phone at 6, 12, and 24 months after scraping surgery.
Evaluation of the obstetric complication rate 12 and 24 months after scraping surgery.Evaluation of the obstetric complication rate 12 and 24 months after scraping surgery.Evaluation using questionnaires asked by post, mail or phone at 12 and 24 months after scraping surgery.
Evaluation of post-surgical synechiae stretch and severity6-8 weeks after scraping surgerySynechiae stretch and severity will be evaluated by the American Fertility Society classification (rAFS).
Consistency assessment between synechiae evaluation performed at the diagnostical hysteroscopy and the synechiae evaluation performed by the 2 experts at the end of the study36 monthsSynechiae stretch and severity will be evaluated by the American Fertility Society classification (rAFS).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026